Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Pre-Hypertension

glucose, (beta-d)-isomer has been researched along with Pre-Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Díaz-Cruz, C; Díaz-Cruz, K; González-Ortiz, M; Martínez-Abundis, E; Patiño-Laguna, AJ; Ramírez-Rodríguez, ZG; Rosales-Rivera, LY2
Loutradis, C; Sarafidis, PA; Theodorakopoulou, MP1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Pre-Hypertension

ArticleYear
Effects of dapagliflozin on blood pressure variability in patients with prediabetes and prehypertension without pharmacological treatment: a randomized trial.
    Blood pressure monitoring, 2020, Volume: 25, Issue:6

    Topics: Benzhydryl Compounds; Blood Pressure; Double-Blind Method; Glucosides; Humans; Prediabetic State; Prehypertension

2020

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Pre-Hypertension

ArticleYear
Dapagliflozin does not affect blood pressure variability in prediabetic prehypertensive subjects.
    Blood pressure monitoring, 2021, 06-01, Volume: 26, Issue:3

    Topics: Benzhydryl Compounds; Blood Pressure; Glucosides; Humans; Prediabetic State; Prehypertension

2021
Response to Comment on Díaz-Cruz et al. Effect of dapagliflozin on blood pressure variability in patients with prediabetes and prehypertension without pharmacological treatment: a randomized trial Blood Press Monit 2020; 25:346-350.
    Blood pressure monitoring, 2021, 06-01, Volume: 26, Issue:3

    Topics: Benzhydryl Compounds; Blood Pressure; Glucosides; Humans; Prediabetic State; Prehypertension

2021